...work includes testing IKKβ inhibition in a rat model of rotator cuff tendinopathy and repair. IMMD Inc....

...obesity. Daiichi Sankyo Co. Ltd. has PLX5622 in Phase I testing to treat rheumatoid arthritis. IMMD Inc....

...survival compared with vehicle. Next steps could include studies in additional models of thrombosis-related diseases. IMMD Inc....

...inhibit IKBKB. Sanofi's IKBKB inhibitor, SAR113945, is in Phase II testing to treat osteoarthritis (OA). IMMD Inc....